Clinical Trial Update: Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update evaluating curcumin's effects on NFE2L2 gene expression, antioxidant capacity, and renal function in diabetic nephropathy, con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Unidad de Investigacion Medica en Enfermedades Renales | Conditions: Chronic Kidney Diseases, Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: UNKNOWN